Trial included patients with poorly controlled hypertension, hyperlipidemia, diabetes
Action Points
- A multicomponent, technologically enabled pharmacist-led intervention tailored to patients' adherence barriers and level of health activation was associated with a small but statisically significant 4.7% improvment in medication adherence, but did not change clinical outcomes in certain chronic conditions.
- Note that in a separate "as-treated" analysis, limited to patients who adhered to the intervention, those receiving the intervention had a 10.4% increase in medication adherence, as well as significantly greater odds of achieving disease control for at least one of the conditions: hypelipidemia, hypertension, and diabetes.
A behavioral-based remote intervention may help increase medication adherence in patients with certain conditions, researchers reported.